A text-messaging intervention appears a safe, feasible, and clinically promising way to augment care for patients with serious mental illness, according to a pilot study published online in Psychiatric Services.
Patients who received botulinum toxin injections at various sites for different conditions reported depression significantly less often, compared with patients undergoing different treatments for the same conditions.
Psych Congress Steering Committee member Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, discusses aspects of the COVID-19 pandemic which may have long-term mental health consequences for children and adolescents.
Psych Congress cochair Charles Raison, MD, will give a virtual keynote speech August 20, 2020, for the University of Louisville Depression Center’s annual benefit. The event is free and open to the public.